Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
73.78
-0.56 (-0.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
33
34
Next >
Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold
September 20, 2022
Via
Benzinga
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
September 19, 2022
As cases of the monkeypox virus continue to grow, the race is on for a way to fight this once-rare disease. Since the first reports of monkeypox infection in the United States started popping up in...
Via
Benzinga
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.
Via
InvestorPlace
WHO Recommends Gilead's COVID-19 Therapy For Severe Disease
September 16, 2022
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Why Is Gilead Sciences (GILD) Stock Up Today?
September 12, 2022
Gilead Sciences has a low valuation, but no growth. Perhaps settling a patent lawsuit will help give GILD stock the boost it needs.
Via
InvestorPlace
Gilead's Trodelvy Shows Improved Overall Survival In Pretreated Breast Cancer Settings
September 08, 2022
Via
Benzinga
Kite Pharma's CAR T-Cell Therapy Wins European Approval In Refractory Leukemia Setting
September 07, 2022
Via
Benzinga
Delayed Generic Entry Is Positive For This Large Pharma's HIV Franchise Sales, Analyst Says
September 15, 2022
Gilead Sciences Inc (NASDAQ: GILD) disclosed agreements with generic manufacturers that delay the U.S. launch of generic TAF products from 2025 to 2031/2032.
Via
Benzinga
Taking Charge of Your Care This Blood Cancer Awareness Month
September 15, 2022
(BPT) - Being empowered often comes from being informed. And when it comes to diseases like blood cancer, having or not having information can make a significant difference in outcomes.
Via
Brandpoint
Topics
Death
Exposures
Death
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
Via
Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it." The...
Via
Benzinga
Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
September 02, 2022
Via
Benzinga
What Is Going on With Gilead Sciences (GILD) Stock Today?
August 16, 2022
GILD stock is the focus of not just one but two news items today, and traders are trying to decide if they're bullish or bearish.
Via
InvestorPlace
Why HIV Testing Should Be an Important and Normal Part of Your Self-Care Routine
September 09, 2022
(BPT) - The COVID-19 pandemic introduced unprecedented challenges and altered ways of living across the globe. Now, more than two years later, the effects are still felt widely. Many non-emergent...
Via
Brandpoint
Exposures
COVID-19
Is First Trust Large Cap Core AlphaDEX ETF (FEX) a Strong ETF Right Now?
September 08, 2022
Making its debut on 05/08/2007, smart beta exchange traded fund First Trust Large Cap Core AlphaDEX ETF (ETF:FEX) provides investors broad exposure to the Style Box - Large Cap Blend category of the...
Via
Benzinga
Gilead's Breast Cancer Drug Improves Progression-Free Survival in HR+/HER2- Metastatic Breast Cancer
September 06, 2022
Via
Benzinga
Everest Medicines Descends To New Depths On String Of Bad News
September 01, 2022
Key Takeaways: The CEO of Everest Medicines resigned two days after the company announced its loss grew sharply in the first half of the year The company also lost an important potential new revenue...
Via
Benzinga
Gilead's Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays
August 22, 2022
Via
Benzinga
Week In Review: Everest Sells Trodelvy Rights Back To Gilead For $455 Million
August 20, 2022
Shanghai Everest Medicines returned rights for Trodelvy to Immunomedics, now a subsidiary of Gilead Sciences, in an agreement worth up to $455 million ($280 million upfront).
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
August 19, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Looking For Ebola Virus Meds? WHO Recommends These Two Antibody Treatments
August 19, 2022
Via
Benzinga
Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions
August 19, 2022
How they handle an upcoming shift in payments will be telling for their tailwind.
Via
Investor's Business Daily
Caribou's Blood Cancer Candidate Shows Response Rates Better Than Novartis,' This Analyst Writes
August 18, 2022
Via
Benzinga
Can Faraday Future (FFIE) Stock Turn Its Cash Crunch Around?
August 16, 2022
Faraday Future (FFIE) stock is on the move Tuesday as investors react to news of a new funding agreement to keep the business going.
Via
InvestorPlace
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,400 Today
August 16, 2022
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 6.41% on an annualized basis producing an average annual return of 14.28%. Currently, Gilead Sciences has a market...
Via
Benzinga
SoftBank Just Gave Nu Holdings (NU) Stock a Big Boost
August 16, 2022
Nu Holdings (NU) stock is on the rise Tuesday as investors react to news of SoftBank (SFTBY) taking a stake in the banking company.
Via
InvestorPlace
After Surprise Overall Survival Data In Metastatic Breast Cancer, Gilead Takes Complete Rights To Trodelvy
August 16, 2022
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via
Benzinga
Why Gilead Sciences Stock Jumped 5% Today
August 15, 2022
Gilead Sciences Inc (NASDAQ: GILD) shares closed higher Monday after the company announced statistically significant and clinically meaning
Via
Benzinga
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.